A wearable positron emission tomography (PET) scanner that rats can wear on their heads has been developed and tested effectively.
In one of the first studies of its kind, UCLA researchers used a unique brain scan to assess the levels...
Early changes to the inferior frontal junction observed in early dementias A key misplaced yet again? Unable to recall a...
Facilitates systematic comparison of mouse models of disorders including schizophrenia, autism A new technology developed by neuroscientists at Cold Spring...
Small phase I study suggests ‘brain pacemaker’ could slow progression of AD A study on a handful of people with...
Scientists have taken a step toward developing a blood test for Alzheimer's, finding a group of markers that hold up in statistical analyses in three independent groups of patients.
Researchers combined genetic data with neuroimaging in order to identify genes associated with amyloid plaque deposits in Alzheimer's disease patients. The study is believed to be the first genome-wide association study of plaque deposits using a specialized PET scan tracer that binds to amyloid.
A new study finds increased amyloid levels in the brains of unmedicated hypertensive adults with a genetic risk factor for Alzheimer's disease.
Preliminary brain scan studies reveal how vagus nerve stimulation brings about changes in brain metabolism weeks prior to patients with depression entering into recovery.
Researchers have successfully tested a new vaccine in primates to battle cocaine addiction. Using neuroimaging techniques, they demonstrated the vaccine prevents cocaine from reaching the brain and producing a dopamine induced high. Human trials could begin within the next year.
Researchers discover early accumulation of amyloid plaques in the temporal lobe is associated with cognitive decline. The finding could serve as a new biomarker for the early detection of Alzheimer's disease.
Researchers have developed a new, non invasive, imaging tool that can visualize myelin damage in patients with MS.
